[ Neoton and thrombolytic therapy of myocardial infarction ] . 
<br>
<br> AIM To <font color="blue">evaluate_1</font> neoton <font color="blue">therapy_1</font> <font color="blue">effects_1</font> in acute myocardial infarction ( MI ) on <font color="blue">systolic_3</font> <font color="blue">function_3</font> <font color="blue">of_3</font> <font color="blue">the_3</font> <font color="blue">left_3</font> <font color="blue">ventricle_3</font> <font color="blue">,_3</font> <font color="blue">arrhythmia_3</font> <font color="blue">and_3</font> <font color="blue">clinical_3</font> <font color="blue">symptoms_3</font> <font color="blue">in_1</font> <font color="blue">patients_1</font> <font color="blue">on_1</font> <font color="blue">thrombolytic_1</font> <font color="blue">therapy_1</font> <font color="blue">(_1</font> <font color="blue">TLT_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> 
<br> MATERIAL AND METHODS 106 males with Q - MI entered the study . 47 received treatment without TLT and neoton , 30 patients received TLT with streptokinase preparations , 29 patients were given streptokinase preparations and neoton . <font color="blue">Left_4</font> <font color="blue">ventricular_4</font> <font color="blue">systolic_4</font> <font color="blue">function_4</font> <font color="blue">was_1</font> <font color="blue">measured_1</font> <font color="blue">by_1</font> <font color="blue">echocardiography_1</font> on day 1 , 3 , 7 , 14 , 21 and 28 ; <font color="blue">arrhythmia_3</font> <font color="blue">was_1</font> <font color="blue">analysed_1</font> <font color="blue">at_1</font> <font color="blue">Holter_1</font> <font color="blue">monitoring_1</font> in day 1 and 2 of MI . 
<br> RESULTS TLT failed to arrest <font color="blue">progression_1</font> <font color="blue">of_1</font> <font color="blue">left_2</font> <font color="blue">ventricular_2</font> <font color="blue">dilation_2</font> by the end of the hospital stay . Patients given neoton in acute period of MI had no increase in the <font color="blue">end_3</font> <font color="blue">systolic_3</font> <font color="blue">and_3</font> <font color="blue">diastolic_3</font> <font color="blue">volumes_3</font> <font color="blue">of_3</font> <font color="blue">the_3</font> <font color="blue">left_3</font> <font color="blue">ventricle_3</font> in the course of the first months after MI onset . <font color="blue">Antiarrhythmic_2</font> <font color="blue">action_2</font> of neoton manifested on MI day 2 . 
<br> CONCLUSION Neoton given to MI patients receiving TLT prevents <font color="blue">progression_2</font> <font color="blue">of_2</font> <font color="blue">left_2</font> <font color="blue">ventricular_2</font> <font color="blue">systolic_2</font> <font color="blue">dysfunction_2</font> <font color="blue">and_1</font> <font color="blue">establishment_1</font> <font color="blue">of_1</font> <font color="blue">predictors_1</font> <font color="blue">of_1</font> <font color="blue">unfavourable_1</font> <font color="blue">outcome_1</font> <font color="blue">._1</font>